Advertisement

Topics

Haber, Inc. Company Profile

11:33 EDT 26th April 2017 | BioPortfolio

Haber, Inc. is a high technology process development company with proprietary technologies in extractive metallurgy and electrochemical separations. The company’s Electromolecular Propulsion (EMP) technology is an electrochemical process that enables the electrically controlled movement or positioning of a variety of different molecules at greater speed and control of the results than conventional methods. In addition, the company has the environmentally friendly Haber Gold Process Four (HGP4), a sulfide reduction, extraction and recovery process and the associated “Aladdin” proprietary processing equipment. For more information, call Florence Tambone 617-710-1598 or visit the company’s website at http://www.habercorp.com


News Articles [7 Associated News Articles listed on BioPortfolio]

Emerging Company Partner David B. Haber Joins WilmerHale in New York

NEW YORK, Jan. 31, 2017 (GLOBE NEWSWIRE) -- David B. Haber has joined WilmerHale as a partner in New York, where his experience serving emerging companies will strengthen the firm's commitment to the...

New insights into DNA repair

A new paper in the prestigious journal Nature from Brandeis researchers in the laboratory of James Haber provides a detailed description of the processes of DNA repair.

Weyl semimetals split water

Catalysis significantly affects our way of life. Catalysis plays an important role in many biological and technological processes. For example, the world's food supply is based on a famous catalytic ...

Will Humans Run Out of Fertilizer?

In this article, Alex Fitzsimmons, an energy-policy analyst based in in Washington, D.C., writes, “Most people don’t think about fertilizer, but few innovations are as central to modern life. In t...

Turkey says could suspend EU migrant deal if no progress on visas

Turkey could re-evaluate or suspend all agreements under its migration deal with the European Union if the bloc does not give a positive response on visa-free travel for Turks, Foreign Minister Mevlut...

Provision Healthcare Recibe Autorización de la FDA para el Sistema de Terapia de Protones ProNova SC360

Friday, December 9th 2016 at 12:21am UTC KNOXVILLE, Tennessee–(BUSINESS WIRE)– La subsidiaria de investigación, desarrollo y fabricación de Provision Healthcare, ProNova Solutions, ha re...

DoctorLogic Partners With DentalWorks to Successfully Launch 164 Unique Websites in Under 6 Months

DALLAS, Jan. 31, 2017 /PRNewswire/ -- Dallas-based software developer, DoctorLogic, recently launched 164 unique websites for DentalWorks and DentalOne Partners, Inc., one of the nation's largest dent...

Drugs and Medications [0 Results]

None

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Effects of Tempol and Quercetin on Human Sperm Function after Cryopreservation.

  BACKGROUND: Quercetin is a flavonoid with high reactive oxygen species (ROS) scavenging and ion chelating activity. It also enhances the activity of antioxidant enzymes and reduces enzymatic act...

Innominate segment deformation during passive hip abduction and external rotation.

Electromagnetic palpation-digitization technique for measurement of innominate motion involves calculation of innominate rotation using the innominate vector length in the neutral (NEUT) and combined ...

N2 activation on Al metal clusters: catalyzing role of BN-doped graphene support.

The successful sustenance of life demands an ambient abiotic process for N2 activation and dissociation. The Bosch-Haber process remains the only abiotic and synthetic means for N2 activation and its ...

Critical elements for human health risk assessment of less than lifetime exposures.

Less than lifetime exposure has confronted risk assessors as to how to interpret the risks for human health in case a chronic health-based limit is exceeded. Intermittent, fluctuating and peak exposur...

Au Sub-Nanoclusters on TiO2 toward Highly Efficient and Selective Electrocatalyst for N2 Conversion to NH3 at Ambient Conditions.

As the NN bond in N2 is one of the strongest bonds in chemistry, the fixation of N2 to ammonia is a kinetically complex and energetically challenging reaction and, up to now, its synthesis is still...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

haber corporation

Since the inception in 1977 the vision of Gary Haber & Haber Corporation was to be and currently is a company dedicated to strengthening artists' and entertainers' careers by providing state-of-the-ar...

Haber, Inc.

Haber, Inc. is a high technology process development company with proprietary technologies in extractive metallurgy and electrochemical separations. The company’s Electromole...

Haber Incorporated

Haber Inc. has been an innovative high tech Company based in New Jersey, U.S.A. Today the company controls several proprietary cutting edge technologies, which are now commercial ready, and has begun ...

Shapiro Haber & Urmy LLP

More Information about "Haber, Inc." on BioPortfolio

We have published hundreds of Haber, Inc. news stories on BioPortfolio along with dozens of Haber, Inc. Clinical Trials and PubMed Articles about Haber, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Haber, Inc. Companies in our database. You can also find out about relevant Haber, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record